Variants at the 9p21 locus and melanoma risk

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Maccioni, Livia ^a   Rachakonda, Panduranga Sivaramakrishna ^a   Bermejo, Justo Lorenzo ^b   Planelles, Dolores ^c   Requena, Celia ^d   Hemminki, Kari ^a,e   Nagore, Eduardo ^d,f   Kumar, Rajiv ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Center for Blood Transfusion   (Spain)

^d INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^e LUND UNIVERSITY   (Sweden)

^f UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BIOINFORMATICS; CANCER RISK; CDKN2A GENE; CHROMOSOME 9P; CHROMOSOME VARIANT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MC1R GENE; MELANOCYTIC NEVUS; MELANOMA SKIN CANCER; MTAP GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; CHROMOSOME 9; GENETIC PREDISPOSITION; GENETICS; MELANOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTOR; SKIN TUMOR;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MELANOMA; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SKIN NEOPLASMS;

EID: 84879823272     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-325     Document Type: Article

References (51)

1. Garbe C, Blum A. Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001, 14(5):280-290. 10.1159/000056358, 11586069.
2. Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front Biosci 2006, 11:1244-1254. 10.2741/1877, 16368510.
3. Maddodi N, Setaluri V. Role of UV in cutaneous melanoma. Photochem Photobiol 2008, vol. 84(2008/02/06 edn):528-536.
4. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev 2005, 14(3):562-566. 10.1158/1055-9965.EPI-04-0564, 15767329.
5. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009, 20(Suppl 6):vi1-vi7. 10.1093/annonc/mdp252, 2712590, 19617292.
6. Han J, Colditz GA, Hunter DJ. Risk factors for skin cancers: a nested case-control study within the Nurses' health study. Int J Epidemiol 2006, 35(6):1514-1521. 10.1093/ije/dyl197, 16943234.
7. Hansson J. Familial cutaneous melanoma. Adv Exp Med Biol 2010, 685:134-145. 10.1007/978-1-4419-6448-9_13, 20687502.
8. Falchi M, Bataille V, Hayward NK, Duffy DL, Bishop JA, Pastinen T, Cervino A, Zhao ZZ, Deloukas P, Soranzo N, et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009, 41(8):915-919. 10.1038/ng.410, 3080738, 19578365.
9. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009, 41(8):920-925. 10.1038/ng.411, 2741419, 19578364.
10. Amos CI, Wang LE, Lee JE, Gershenwald JE, Chen WV, Fang S, Kosoy R, Zhang M, Qureshi AA, Vattathil S, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet 2011, 20(24):5012-5023. 10.1093/hmg/ddr415, 3298855, 21926416.
11. Macgregor S, Montgomery GW, Liu JZ, Zhao ZZ, Henders AK, Stark M, Schmid H, Holland EA, Duffy DL, Zhang M, et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 2011, 43(11):1114-1118. 10.1038/ng.958, 3227560, 21983785.
12. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 2011, 43(11):1108-1113. 10.1038/ng.959, 3251256, 21983787.
13. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 1999, 91(5):446-452. 10.1093/jnci/91.5.446, 10070944.
14. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 2001, 95(6):388-393. 10.1002/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6, 11668523.
15. Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Zaluga E, Maleszka R, Kladny J, Gorski B, et al. CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 2005, 65(3):835-839.
16. Ibarrola-Villava M, Fernandez LP, Pita G, Bravo J, Floristan U, Sendagorta E, Feito M, Aviles JA, Martin-Gonzalez M, Lazaro P, et al. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2. Exp Dermatol 2010, 19(9):836-844. 10.1111/j.1600-0625.2010.01115.x, 20629734.
17. Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I, Nicolaou V, Spyrou G, Evangelou E, Roehr JT, Kodela E, Katsambas A, et al. Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma. J Natl Cancer Inst 2011, 103(16):1227-1235. 10.1093/jnci/djr219, 21693730.
18. Scherer D, Nagore E, Bermejo JL, Figl A, Botella-Estrada R, Thirumaran RK, Angelini S, Hemminki K, Schadendorf D, Kumar R. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations. Int J Cancer 2009, 125(8):1868-1875. 10.1002/ijc.24548, 19585506.
19. Maccioni L, Rachakonda PS, Scherer D, Bermejo JL, Planelles D, Requena C, Hemminki K, Nagore E, Kumar R. Variants at chromosome 20 (ASIP locus) and melanoma risk. Int J Cancer 2013, 132(1):42-54. 10.1002/ijc.27648, 22628150.
20. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009, 41(8):899-904. 10.1038/ng.407, 19578367.
21. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009, 41(8):905-908. 10.1038/ng.408, 2923561, 19578366.
22. Saxena R, Voight BF, Lyssenko V, Burtt NP, De Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316(5829):1331-1336.
23. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316(5829):1341-1345. 10.1126/science.1142382, 3214617, 17463248.
24. Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, Strachan DP, Rayner NW, Walker M, Hitman GA, Doney AS, et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 2009, 58(2):505-510. 2628627, 19056611.
25. Zeggini E, Scott LJ, Saxena R, Voight BF, Marchini JL, Hu T, De Bakker PI, Abecasis GR, Almgren P, Andersen G, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008, 40(5):638-645. 10.1038/ng.120, 2672416, 18372903.
26. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, Ikegami H, Sugiyama T, Katsuya T, Miyagishi M, et al. Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009, 58(7):1690-1699. 10.2337/db08-1494, 2699880, 19401414.
27. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42(7):579-589. 10.1038/ng.609, 3080658, 20581827.
28. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007, 316(5830):1491-1493. 10.1126/science.1142842, 17478679.
29. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010, 42(6):492-494. 10.1038/ng.585, 3434228, 20453839.
30. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B, Benediktsdottir KR, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 2009, 41(8):909-914. 10.1038/ng.412, 2973331, 19578363.
31. Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D'Agostino RB, Fox CS, Govindaraju DR, Guo CY, Heard-Costa NL, Hwang SJ, et al. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 2007, 8(Suppl 1):S5. 10.1186/1471-2350-8-S1-S5, 1995607, 17903304.
32. Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG, Hayward NK, Duffy DL. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma. Twin research and human genetics : the official journal of the International Society for Twin Studies 2011, 14(5):422-432.
33. Behrmann I, Wallner S, Komyod W, Heinrich PC, Schuierer M, Buettner R, Bosserhoff AK. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 2003, 163(2):683-690. 10.1016/S0002-9440(10)63695-4, 1868213, 12875987.
34. Stevens AP, Spangler B, Wallner S, Kreutz M, Dettmer K, Oefner PJ, Bosserhoff AK. Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of malignant melanoma. J Cell Biochem 2009, 106(2):210-219. 10.1002/jcb.21984, 19097084.
35. Mowen KA, Tang J, Zhu W, Schurter BT, Shuai K, Herschman HR, David M. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 2001, 104(5):731-741. 10.1016/S0092-8674(01)00269-0, 11257227.
36. Wild PJ, Meyer S, Landthaler M, Hofstaedter F, Bosserhoff AK. A potential predictive marker for response to interferon in malignant melanoma. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG 2007, 5(6):456-459. 10.1111/j.1610-0387.2007.06303.x, 17537037.
37. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010, 42(6):504-507. 10.1038/ng.586, 3632836, 20453838.
38. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, Paulsson-Berne G, Hamsten A, Hugh W, Franco-Cereceda A, Gabrielsen A, et al. Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 2009, 4(11):e7677. 10.1371/journal.pone.0007677, 2765615, 19888323.
39. Pasmant E, Sabbagh A, Vidaud M, Bieche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J 2011, 25(2):444-448. 10.1096/fj.10-172452, 20956613.
40. Sato K, Nakagawa H, Tajima A, Yoshida K, Inoue I. ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1. Oncol Rep 2010, 24(3):701-707.
41. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene 2011, 30(16):1956-1962. 10.1038/onc.2010.568, 3230933, 21151178.
42. Spica T, Portela M, Gerard B, Formicone F, Descamps V, Crickx B, Ollivaud L, Archimbaud A, Dupin N, Wolkenstein P, et al. The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006, 126(7):1657-1660. 10.1038/sj.jid.5700293, 16614725.
43. Pjanova D, Engele L, Randerson-Moor JA, Harland M, Bishop DT, Newton Bishop JA, Taylor C, Debniak T, Lubinski J, Kleina R, et al. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res 2007, 17(3):185-191. 10.1097/CMR.0b013e328014a2cd, 17505264.
44. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Bjorklund M, Wei G, Yan J, Niittymaki I, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009, 41(8):885-890. 10.1038/ng.406, 19561604.
45. Visser M, Kayser M, Palstra RJ. HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. Genome Res 2012, 22(3):446-455. 10.1101/gr.128652.111, 3290780, 22234890.
46. Cooper DN. Functional intronic polymorphisms: buried treasure awaiting discovery within our genes. Hum Genomics 2010, 4(5):284-288. 10.1186/1479-7364-4-5-284, 3500160, 20650817.
47. Ward AJ, Cooper TA. The pathobiology of splicing. J Pathol 2010, 220(2):152-163. 2855871, 19918805.
48. Bloethner S, Scherer D, Drechsel M, Hemminki K, Kumar R. Malignant melanoma-a genetic overview. Actas Dermosifiliogr 2009, 100(Suppl 1):38-51.
49. Chin L. The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 2003, 3(8):559-570. 10.1038/nrc1145, 12894244.
50. Ruas M, Peters G. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1998, 1378(2):F115-177.
51. Latres E, Malumbres M, Sotillo R, Martin J, Ortega S, Martin-Caballero J, Flores JM, Cordon-Cardo C, Barbacid M. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis. EMBO J 2000, 19(13):3496-3506. 10.1093/emboj/19.13.3496, 313938, 10880462.